In colon cancer, the reduction of YAP1 expression triggered hyperactivity of the Wnt/beta-catenin pathway, supporting the link between Hippo/YAP1 signaling and the Wnt/beta-catenin pathway [18]. The gene discussed is YAP1; the disease is malignant colon neoplasm.